Chesley Taft & Associates LLC Bristol Myers Squibb CO Transaction History

Chesley Taft & Associates LLC

  • $2.08 Billion
  • Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 5,250 shares of BMY stock, worth $309,067. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,250
Previous 4,998 5.04%
Holding current value
$309,067
Previous $207,000 30.92%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
BUY
$39.66 - $51.75 $9,994 - $13,041
252 Added 5.04%
5,250 $271,000
Q2 2024

Jul 19, 2024
BUY
$40.25 - $52.99 $8,533 - $11,233
212 Added 4.43%
4,998 $207,000
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $7,676 - $8,704
-160 Reduced 3.23%
4,786 $259,000
Q4 2023

Jan 11, 2024
SELL
$48.48 - $57.85 $845,539 - $1.01 Million
-17,441 Reduced 77.91%
4,946 $253,000
Q3 2023

Oct 10, 2023
SELL
$57.89 - $64.73 $4,052 - $4,531
-70 Reduced 0.31%
22,387 $1.3 Million
Q2 2023

Jul 17, 2023
SELL
$63.71 - $70.74 $12,423 - $13,794
-195 Reduced 0.86%
22,457 $1.44 Million
Q4 2022

Jan 19, 2023
BUY
$68.48 - $81.09 $11,367 - $13,460
166 Added 0.74%
22,652 $0
Q3 2022

Oct 13, 2022
SELL
$0.13 - $76.84 $17 - $10,603
-138 Reduced 0.61%
22,486 $1.6 Million
Q2 2022

Jul 07, 2022
BUY
$72.62 - $79.98 $7,479 - $8,237
103 Added 0.46%
22,624 $1.74 Million
Q4 2021

Jan 05, 2022
SELL
$53.63 - $62.52 $22,524 - $26,258
-420 Reduced 1.83%
22,521 $1.4 Million
Q3 2021

Oct 05, 2021
BUY
$59.17 - $69.31 $4,437 - $5,198
75 Added 0.33%
22,941 $1.36 Million
Q4 2020

Jan 11, 2021
BUY
$57.74 - $65.43 $37,242 - $42,202
645 Added 2.9%
22,866 $1.42 Million
Q3 2020

Oct 08, 2020
BUY
$57.43 - $63.64 $258,722 - $286,698
4,505 Added 25.43%
22,221 $1.34 Million
Q2 2020

Jul 08, 2020
BUY
$54.82 - $64.09 $119,123 - $139,267
2,173 Added 13.98%
17,716 $1.04 Million
Q1 2020

Apr 15, 2020
BUY
$46.4 - $67.43 $531,512 - $772,410
11,455 Added 280.21%
15,543 $866,000
Q4 2019

Jan 10, 2020
BUY
$49.21 - $64.19 $201,170 - $262,408
4,088 New
4,088 $262,000
Q4 2018

Jan 07, 2019
SELL
$48.76 - $63.23 $752,123 - $975,322
-15,425 Closed
0 $0
Q2 2018

Jul 12, 2018
SELL
$50.53 - $62.98 $10,106 - $12,596
-200 Reduced 1.28%
15,425 $854,000
Q1 2018

Apr 11, 2018
SELL
$59.92 - $68.98 $6.14 Million - $7.07 Million
-102,450 Reduced 86.77%
15,625 $988,000
Q4 2017

Jan 10, 2018
BUY
$59.94 - $65.35 $265,234 - $289,173
4,425 Added 3.89%
118,075 $7.24 Million
Q3 2017

Oct 13, 2017
BUY
$55.23 - $63.74 $6.28 Million - $7.24 Million
113,650
113,650 $7.24 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email